Table 6 Kaplan-Meier time-to-event estimates of clinical outcomes
12 months | 3 years | |||||
|---|---|---|---|---|---|---|
Stent N (%) (95% CI) | BMT N (%) (95% CI) | P value | Stent N (%) (95% CI) | BMT N (%) (95% CI) | P value | |
MACCEa | 1 (2.9) (0.4, 19.1) | 2 (5.3) (1.3, 19.5) | 0.526 | 4 (14.8) (5.8, 35.1) | 3 (12.0) (3.5, 36.8) | 0.982 |
Death | 1 (2.3) (0.3, 15.4) | 1 (3.1) (0.4, 20.2) | 0.955 | 4 (13.8) (5.3, 33.3) | 2 (9.2) (2.2, 34.1 | 0.639 |
Renal death | 1 (2.2) (0.3, 14.7) | 0 (0.0) | 1.000 | 1 (2.2) (0.3, 14.7) | 0 (0.0) | 1.00 |
Cardiac death | 0 (0.0) | 0 (0.0) | > 0.999 | 2 (7.9) (2.0, 28.1) | 0 (0.0) (0.0, 0.0) | 0.495 |
Stroke | 1 (2.9) (0.4, 19.1) | 1 (2.7) (0.4, 17.7) | 0.966 | 1 (2.9) (0.4, 19.1) | 2 (9.7) (2.2, 37.3) | 0.447 |
Myocardial infarction | 0 (0.0) | 0 (0.0) | > 0.999 | 1 (4.3) (0.6, 27.1) | 0 (0.0) (0.0, 0.0) | > 0.999 |
Hospitalization for congestive heart failure | 0 (0.0) | 1 (2.6) (0.4, 16.8) | 0.477 | 1 (4.2) (0.6, 26.1) | 1 (2.6) (0.4, 16.8) | 0.855 |
Progressive renal insufficiency (i.e. need for dialysis) | 1 (2.4) (0.3, 16.1) | 1 (2.7) (0.4, 17.7) | 0.978 | 1 (2.4) (0.3, 16.1) | 1 (2.7) (0.4, 17.7) | 0.978 |
Permanent renal replacement therapy | 1 (2.4) (0.3, 16.1) | 0 (0.0) | > 0.999 | 1 (2.4) (0.3, 16.1) | 0 (0.0) | > 0.999 |
Target vessel (re)vascularization | 1 (3.0) (0.4, 19.6) | 4 (11.0) (4.3, 26.8) | 0.142 | 1 (3.0) (0.4, 19.6) | 8 (29.4) (15.4, 51.6) | 0.008 |
Target lesion (re)vascularization | 1 (3.0) (0.4, 19.6) | 4 (11.0) (4.3, 26.8) | 0.142 | 1 (3.0) (0.4, 19.6) | 8 (29.4) (15.4, 51.6) | 0.008 |